Thromboxane Receptor Antagonist to Improve Endothelial Function

Clinical trial NCT03962855 · COMPLETED

Trial details

NCT number: NCT03962855
Sponsor: Jeffrey Rade
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Cardiovascular Diseases Vascular Dilation

Start date: 2019-09-20
Primary completion: 2022-11-07
Enrollment: 57

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.